Nasenspray Erwachsene (Xylometazoline Hydrochloride)

Xylometazoline is a selective alpha‑adrenergic agonist. By stimulating alpha receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces swelling and opens the nasal passages, providing rapid decongestion.

The specific dose and frequency are determined by the prescribing healthcare professional. Typically, the product is used no more than two sprays per nostril every 12 hours, and treatment should not exceed three to five days without medical advice.

Safety data for xylometazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the spray to weigh potential benefits against risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Xylometazoline provides rapid vasoconstriction similar to other topical decongestants such as oxymetazoline. Compared with systemic decongestants, it acts locally, reducing systemic side effects, but it shares the same risk of rebound congestion if used beyond the recommended duration.

Store the spray at room temperature, ideally below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product integrity.

The spray is applied directly into each nostril while the head is upright. The user gently inserts the nozzle, presses the pump to deliver the recommended number of sprays, and then avoids blowing the nose for a few minutes to allow absorption.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, arrhythmias, and rare allergic reactions such as anaphylaxis. Any signs of these conditions require immediate medical attention.

Individuals with known hypersensitivity to xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those who have used other nasal decongestants for more than the recommended period.